Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Many patients experience significant weight loss within six months of starting treatment
The study was funded by WW International
Diabetes guidelines from major organizations support adding SGLT-2 inhibitors and/or GLP-1 agonists to metformin therapy for patients with type 2 diabetes and established CVD, 510 and most guidelines support their use in patients at high risk of cardiovascular events
In fact, all patients, independent of the treatment strategy, had less than expected HbA 1c reductions
US$ 20.12
US$ 29.23
US$ 26.15
US$ 28.29
US$ 29.88
